Isolation and Identification of New Sildenafil Analogues from Dietary Supplements
YUNG-CHIH LIAO1,2*, KUO-CHIH LAI2, HUI-CHUN LEE2, YI-CHU LIU2, YUN-LIAN LIN3
AND DANIEL YANG-CHIH SHIH2
1. Center for Drug Evaluation, Taiwan, R.O.C.
2. Food and Drug Administration, Department of Health, Executive Yuan, Taiwan, R.O.C.
3. National Research Institute of Chinese Medicine, Taiwan, R.O.C.
(Received: March 17, 2012; Accepted: November 13, 2012)
ABSTRACT
Three derivatized thio-sildenafil compounds were isolated from herbal health supplements. The structures of these three compounds were determined by NMR, high resolution MS, LC/MS/MS, UV and IR spectroscopy. Compound 1 and 2 have been identified as propoxyphenyl thioaildenafil and propoxyphenyl aildenafil, respectively. Compound 3, named propoxyphenyl hydroxyethylthiosildenafil, is an analogue of thiosildenafil. The major difference between compound 3 and thiosildenafil is that propoxy and hydroxyethyl groups in compound 3 replaced the function groups of ethoxyl and methyl in thiosildenafil. Since their structures were similar to that of sildenafil or thiosildenafil, according to structure-activity relationship, the side effects of these analogues might be also associated with that of sildenafil or thio-sildenafil. Based on this study, these three analogues have been included in the inspection list of illegal adulterants in TFDA.
Key words: propoxyphenyl hydroxyethylthiosildenafil, propoxyphenyl aildenafil, propoxyphenyl thioaildenafil, NMR, TFDA